Dr.Jothydev Kesavadev presented the original research from JDC on �Continuous Glucose Monitoring in 432 T2D Patients for Assessment of Safety and Cost effectiveness in Reaching A1C Targets� on 16th June at the 74th Scientific Sessions, held at the Moscone Center in San Francisco from June 13-17. CGM was projected to reduce lifetime probability of hypoglycemic episodes to be recommended as routine in T2D to achieve safe A1c targets with confidence. The convention brought together more than 17,300 attendees from more than 100 countries. Participants had the opportunity to connect and experience more than 2,000 original research presentations from more than 800 speakers as well as 3,000 abstract submissions.